Manufacturing Associate, Cell Therapy in Devens, MA at Bristol-Myers Squibb

Devens, Massachusetts, United States

Apply Now

Not SpecifiedCompensation

Entry Level & New Grad, Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Biotechnology, PharmaceuticalsIndustries

Requirements

High school diploma and 0-2 years of experience in cGMP bioprocessing manufacturing, cell therapy manufacturing or relevant experience (Bachelors in relevant science or engineering discipline preferred)
Ability to work assigned shift (Day: 6am–6pm or Night: 6pm–6am, rotating shift including holidays and weekends, onsite)
Ability to work in a cleanroom environment and perform aseptic processing
Comfortable being exposed to human blood components
Ability to be in close proximity to strong magnets
Knowledge of cGMP regulations and FDA guidance applicable to biologics and cell therapy manufacturing preferred
Physical ability to stand/walk for several hours at a time while operating manufacturing/computer equipment and carry weight

Responsibilities

Performing patient process unit operations and support operations described in standard operating procedures and batch records
Completing documentation required by process transfer protocols, validation protocols, standard operating procedures, and batch records
Performing tasks in a manner consistent with safety policies, quality systems, and GMP requirements
Completing training assignments to ensure necessary technical skills and knowledge
Assisting in setting up manufacturing areas and equipment/fixtures
Performing facility and equipment commissioning activities
Referencing Batch Records, Standard Operating Procedures, and Work Instructions to successfully complete manufacturing operations
Executing daily unit operations schedule that includes people, product, and material flow across multiple shifts
Working in a cleanroom environment and performing aseptic processing; maintaining manufacturing environmental conditions (Non-Viable Particulates and Viable microbial levels per controlled area classification specifications) by performing area disinfection regimen as required to meet global Health Authority requirements

Skills

Cell Therapy

GMP

Manufacturing Operations

Unit Operations

Aseptic Processing

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free